HTx holds a follow-up ‘Policy Sandbox’ event to discuss the acceptability of outcomes-based agreements as a way of reimbursing high-cost innovative medicines. Following a policy sandbox event in November 2022 to discuss the suitability of outcome-based agreements (OBAs) to support the sustainable reimbursement of advanced therapy medicinal products (ATMPs), HTx partners, led...
The conceptual framework of the HTx case study on Diabetes was presented at the poster section of the International Conference of Advanced Technologies & Treatments for Diabetes in Madrid, held between 19-22 February 2020. The HTx consortium was represented by Gema García Sáez and Maria Elena Hernando from the Universidad Politécnica...
The framework and potentials of HTx were discussed at the ISPOR Europe 2019 conference within the ISPOR IDEAS LAB in Copenhagen, November 2019. HTx was presented by Wim Goettsch, Associate Professor for HTA at Utrecht University (Utrecht, Netherlands). You can find the abstract of the ISPOR...
The concept of the HTx diabetes case study was presented at the Annual Conference of the Biomedical Engineering Spanish Society held between 27-29 November 2019, in Santander, Spain. The HTx Consortium was represented by the Universidad Politécnica de Madrid, (Madrid, Spain). Scroll down for the poster abstract (in...
The concept and aims of the HTx project, highlighting the potentials for collaboration was disseminated extensively for various stakeholders in Bulgaria during 2019. These activities - lead by Guenka Petrova from the Medical University of Sofia - included: June 7, 2019 - HTx concept presented...
The early results of HTx were presented at the Graduate School for Health Sciences Symposium (November 19 - 20, 2019) in Thun, Switzerland by two PhD students of University of Bern. Poster title: 'A two-stage prediction model for heterogeneous effects for many treatment options' Poster presenter:...
The HTx project was presented in a keynote lecture at the Pharmaceutical Pricing and Reimbursement (PPRI) Conference in Vienna (Austria), on the 24th of October 2019. Title: The need for better HTA methodology for more complex and personalised medicine Presenter: Wim Goettsch, Utrecht University, The Netherlands The presentation...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]A great contribution of HTx’s work was presented at the XXXIst Conference of the Austro-Swiss Region [ ROeS ] of the International Biometric Society in Lausanne, Switzerland, September 9-12, 2019. The title of the presentation was ’ A two-stage...
In June 2019, three representatives of the HTx Consortium attended the Eurordis Summer School in Barcelona, to introduce future patient experts and advocates to the aims, methods and ambitions of the HTx project. The Eurordis Summer School is a one-week face-to-face training for patient advocates, taking...
Pall Jonsson, Associate Director at NICE, participated in a spotlight panel at the ISPOR Annual in May 2019 on the use of AI in healthcare. He outlined some of work within HTx that aims to better understand how AI can be used in healthcare research and delivery....